Not applicableStudy completedNCT00998621What this trial is testingADHEPTA Study: Adherence Questionnaire in Hepatitis CWho this might be right forHepatitis C, ChronicHIV Infection Fundacion IMIM 1,120
Testing effectiveness (Phase 2)Study completedNCT00148863What this trial is testingInterferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic French National Agency for Research on AIDS and Viral Hepatitis 65
Post-approval studies (Phase 4)UnknownNCT03888729What this trial is testingSimplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)Who this might be right forHepatitis C, Chronic Partners in Health 100
Testing effectiveness (Phase 2)Study completedNCT00030030What this trial is testingEvaluating Silymarin for Chronic Hepatitis CWho this might be right forHepatitis C, Chronic National Center for Complementary and Integrative Health (NCCIH)
Not applicableUnknownNCT04952207What this trial is testingEffectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Qing XIe 300
Testing effectiveness (Phase 2)Study completedNCT02226939What this trial is testingAntiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis CWho this might be right forLiver CirrhosisHepatitis C, Chronic Boehringer Ingelheim 10
Testing effectiveness (Phase 2)Study completedNCT00797745What this trial is testingA Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 111
Post-approval studies (Phase 4)Study completedNCT00532701What this trial is testingPeginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRWho this might be right forChronic Hepatitis C National Taiwan University Hospital 880
Testing effectiveness (Phase 2)Study completedNCT02175758What this trial is testingSafety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV InfectionWho this might be right forHepatitis C Virus Infection Gilead Sciences 106
Large-scale testing (Phase 3)Study completedNCT00230958What this trial is testingStudy of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveWho this might be right forChronic Hepatitis C Bausch Health Americas, Inc. 900
Not applicableUnknownNCT00399815What this trial is testingNoninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Cliniques universitaires Saint-Luc- Université Catholique de Louvain 40
Not applicableStudy completedNCT01705717What this trial is testingA Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 49
Large-scale testing (Phase 3)WithdrawnNCT01871662What this trial is testingRandomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Rottapharm
Testing effectiveness (Phase 2)Ended earlyNCT00305383What this trial is testingViral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Bausch Health Americas, Inc. 100
Post-approval studies (Phase 4)Study completedNCT00394277What this trial is testingInduction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 1,175
Testing effectiveness (Phase 2)Study completedNCT02994056What this trial is testingEvaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C CirrhosisWho this might be right forHepatitis C Virus Infection Gilead Sciences 32
Not applicableStudy completedNCT02817594What this trial is testingReal World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis CWho this might be right forChronic Hepatitis C AbbVie 51
Not applicableStudy completedNCT02726022What this trial is testingA Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) LevelsWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Study completedNCT01911845What this trial is testingAn Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or BuprenorphineWho this might be right forChronic Hepatitis C InfectionChronic Hepatitis C AbbVie 38
Post-approval studies (Phase 4)Study completedNCT02964091What this trial is testingSimplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing WorldWho this might be right forChronic Hepatitis C Partners in Health 300